Michelle L. Basil
Overview
Michelle L. Basil received an average of $2M in total compensation, including $456K in salary, at Haemonetics from 2018 to 2022.
Source: SEC filings on June 17, 2022, June 17, 2021, June 8, 2020, and June 12, 2019.
Related executives
We found 16 more executives who work or worked at Haemonetics.
Christopher Simon
Haemonetics
Chief Executive Officer
William Burke
Haemonetics
Chief Financial Officer
Stewart Strong
Haemonetics
President, Global Hospital
Josep Llorens
Haemonetics
Executive Vice President, Global Manufacturing and Supply Chain
Anila Lingamneni
Haemonetics
Executive Vice President, Chief Technogy Officer
Jacqueline Scanlan
Haemonetics
Senior Vice President, Global Human Resources
Said Bolorforosh
Haemonetics
Chief Technology Officer
Brian Concannon
Haemonetics
Chief Executive Officer
News
Haemonetics CEO Christopher Simon's 2022 pay rises 1% to $8.7M
June 17, 2022
Haemonetics CEO Christopher Simon's 2021 pay slips 8% to $8.6M
June 17, 2021
Haemonetics CEO Christopher Simon's 2020 pay rises 10% to $9.4M
June 8, 2020
Haemonetics CEO Christopher Simon's 2019 pay rises 9% to $8.6M
June 12, 2019